TLR2 and brain ischemia: Recent studies have shown that, compared with a control group, the number of CD11b-positive cells was significantly reduced, and there was a significant reduction in the neuronal death rate in C57BL mice arterially injected with a TLR2 antibody (clone T 2.5) 45 min after cerebral ischemia [34].